Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination

06/01/2010
By Centers for Disease Control and Prevention (U.S.) ...
Series: HAN ; 314

[PDF-611.60 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration.

Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. Less -
Description:

Tuesday, June 01, 2010, 10:25 EST (10:25 AM EST)

CDCHAN-00314-2010-06-01-ADV-N

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals not to use certain intravenous (IV) bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Microbiological analysis identified the matter in one of the bags as a Cladosporium mold. Molds of this type can cause infections in susceptible patients, such as immunocompromised individuals. At this time, FDA is not aware of any reports of injuries due to administration of these products. Affected products include any metronidazole, ondansetron, and ciprofloxacin manufactured by Claris Lifesciences Limited and sold under the following labels: Claris, Sagent Pharmaceuticals, Pfizer, West-Ward Pharmaceuticals
Subjects:

[+]

Ciprofloxacin Drug Contamination Injections, Intravenous Metronidazole Ondansetron
Series:

HAN ; 314
Document Type:

HAN Health Advisory
Place as Subject:

United States
Collection(s):

Health Alert Network (HAN)
Main Document Checksum:

[+]

urn:sha-512:7e071de4a68e57729c7c132d5566f6798dcbf0633d9a073067426bb9938cf0b0803fed031c96ad6dbeec0e64d7e2dc728b93d9e43c07524cd3acc3396f9c2b21
Download URL:

https://stacks.cdc.gov/view/cdc/25223/cdc_25223_DS1.pdf
File Type:

No Additional Files

More +

Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination

Details:

Supporting Files

You May Also Like